Table 1.
| Total No. | Age Mean (Range) | NIHSS Median (Range) | Lesion Volume (mm3) Median (Range) | Male | Female | |
| Nonstroke control subjects 1) | 17 | 65 | NA | NA | 6 | 8 |
| (50–94) | ||||||
| Total patients included | 93 | 69.8 | 15 | 141120 | 47 | 46 |
| (41–92) | (2–26) | (441–2 954 304) | ||||
| Infected cohort2)3) | 17 | 70.6 | 17 | 162180 | 10 | 7 |
| (49–92) | (2–26) | (10230–2 954 304) | ||||
| Noninfected cohort 3) | 24 | 63.2 | 9 | 64638 | 14 | 10 |
| (43–88) | (2–20) | (441–2 551 298) | ||||
| Infection status not set 3) | 52 | 72.5 | 17 | 131585 | 23 | 29 |
| (41–89) | (3–26) | (689–617792) |
1)
Nonstroke control subjects were healthy individuals (n = 12) or had other diseases (Parkinson's disease n = 1, Bell's palsy n = 1, hypertensive crisis n = 1, diabetes mellitus n = 1,or polyneuropathy n = 1).
2)
Infected cohort patients suffered from: 14 pneumonia n = 14, ,fever of unknown origin n = 1, erysipelas n = 1, intravenous catheter abscess n = 1. 3 patients additionally aquired urinary tract infection.
3)
Patients were assigned as described in material and methods section.
NA: not applicable.